CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019
Cash flows from operating activities:
Net income (loss)	$ (152,542)	$ (36,129)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Equity in (earnings) losses of unconsolidated ventures	35,756	4,629
Depreciation and amortization	32,984	38,361
Impairment loss	91,437	10,146
Capitalized interest for mortgage and other notes payable	222	193
Amortization of below market debt	1,536	1,497
Straight-line rental income, net and amortization of lease inducements	70	(428)
Amortization of discount/accretion of premium on investments	(61)	(55)
Amortization of deferred financing costs	941	909
Amortization of equity-based compensation	77	91
Realized (gain) loss on investments and other	0	(5,722)
Allowance for uncollectible accounts	1,004	460
Issuance of common stock as payment for asset management fees	5,000	5,000
Changes in assets and liabilities:
Receivables	(1,282)	53
Other assets	(298)	48
Due to related party	(2,332)	(2,033)
Escrow deposits payable	371	35
Accounts payable and accrued expenses	4,516	(7,741)
Other liabilities	34	(836)
Net cash provided by operating activities	17,433	8,478
Cash flows from investing activities:
Capital expenditures for operating real estate investments	(5,362)	(8,158)
Sale of operating real estate	0	19,618
Investment in unconsolidated ventures	0	(39,801)
Distributions from unconsolidated ventures	1,765	12,079
Other assets	(290)	583
Net cash (used in) provided by investing activities	(3,887)	(15,679)
Cash flows from financing activities:
Repayment of mortgage notes	(8,112)	(27,865)
Borrowings from line of credit - related party	35,000	0
Payments under finance leases	(307)	(284)
Shares redeemed for cash	(1,998)	(5,182)
Distributions paid on common stock	0	(10,813)
Proceeds from distribution reinvestment plan	0	4,876
Contributions from non-controlling interests	93	318
Distributions to non-controlling interests	(139)	(139)
Net cash (used in) provided by financing activities	24,537	(39,089)
Net (decrease) increase in cash, cash equivalents and restricted cash	38,083	(46,290)
Cash, cash equivalents and restricted cash-beginning of period	58,820	94,508
Cash, cash equivalents and restricted cash-end of period	96,903	48,218
Supplemental disclosure of non-cash investing and financing activities:
Accrued capital expenditures	500	$ 609
Assets acquired under finance leases	$ 112